Prevalence of vitamin D deficiency and insufficiency in Bulgarian patients with chronic Hepatitis C viral infection

References

• Institute of Medicine. Dietary reference intakes for calcium and vitamin D. In: Ross AC, Taylor CL, Yaktine AL, Del Valle HB (eds). Washington, DC: National Academies Press; 2011:96–111.
   Google Scholar
• Hollis BW. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 2005;135:317–22.
   PubMed Web of Science ®Google Scholar
• Beard JA, Bearden A, Striker R. Vitamin D and the anti-viral state. J Clin Virol 2011;50:194–200.
   PubMed Web of Science ®Google Scholar
• Chesney RW. Vitamin D and The Magic Mountain: the anti-infectious role of the vitamin. J Pediatr 2010;156:698–703.
   PubMed Web of Science ®Google Scholar
• Petta S, Cammà C, Scazzone C, Tripodo C, Di Marco V, Bono A, Cabibi D, Licata G, Porcasi R, Marchesini G, Craxì A. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology 2010;51:1158–67.
   PubMed Web of Science ®Google Scholar
• Duarte MP, Farias ML, Coelho HS, Mendonça LM, Stabnov LM, do Carmo d Oliveira M, Lamy RA, Oliveira DS. Calcium-parathyroid hormone-vitamin D axis and metabolic bone disease in chronic viral liver disease. J Gastroenterol Hepatol 2001;16:1022–7.
   PubMed Web of Science ®Google Scholar
• Fisher L, Fisher A. Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease. Clin Gastroenterol Hepatol 2007;5:513–20.
   PubMed Web of Science ®Google Scholar
• Lim LY, Chalasani N. Vitamin D deficiency in patients with chronic liver disease and cirrhosis. Curr Gastroenterol Rep. 2012;14:67–73.
   PubMedGoogle Scholar
• Barchetta I, Angelico F, Del Ben M, Baroni MG, Pozzilli P, Morini S, Cavallo MG. Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med 2011;9:85.
   PubMed Web of Science ®Google Scholar
• Malham M, Jørgensen SP, Ott P, Agnholt J, Vilstrup H, Borre M, Dahlerup JF. Vitamin D deficiency in cirrhosis relates to liver dysfunction rather than aetiology. World J Gastroenterol 2011;17:922–5.
   PubMed Web of Science ®Google Scholar
• Masuda S, Okano T, Osawa K, Shinjo M, Suematsu T, Kobayashi T. Concentrations of vitamin D metabolites in plasma of patients with liver cirrhosis. J Nut Sci Vitaminol 1989;35:225–34.
   PubMed Web of Science ®Google Scholar
• Monegal A, Navasa M, Guañabens N, Peris P, Pons F, Martinez de Osaba MJ, Rimola A, Rodés J, Muñoz-Gómez J. Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation. Calcif Tissue Int 1997;60:148–54.
   PubMed Web of Science ®Google Scholar
• Hofmann WP, Kronenberger B, Bojunga J, Stamm B, Herrmann E, Bücker A, Mihm U, von Wagner M, Zeuzem S, Sarrazin C. Prospective study of bone mineral density and metabolism in patients with chronic hepatitis C during pegylated interferon alfa and ribavirin therapy. J Viral Hepat 2008;15:790–6.
   PubMed Web of Science ®Google Scholar
• Petta S, Grimaudo S, Marco VD, Scazzone C, Macaluso FS, Cammà C, Cabibi D, Pipitone R, Craxì A. Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients. J Viral Hepat 2013;20:486–93.
   PubMed Web of Science ®Google Scholar
• Mangia A, Minerva N, Bacca D, Cozzolongo R, Ricci GL, Carretta V, Vinelli F, Scotto G, Montalto G, Romano M, Cristofaro G, Mottola L, Spirito F, Andriulli A. Individualized treatment duration for Hepatitis C Genotype 1 patients: a randomized controlled trial. Hepatology 2008;47:43–50.
   PubMed Web of Science ®Google Scholar
• Rode A, Fourlanos S, Nicoll A. Oral vitamin D replacement is effective in chronic liver disease. Gastroenterol Clin Biol 2010;34:618–20.
   PubMedGoogle Scholar
• Gal-Tanamy M, Bachmetov L, Ravid A, Koren R, Erman A, Tur-Kaspa R, Zemel R. Vitamin D: an innate antiviral agent suppressing hepatitis C virus in human hepatocytes. Hepatology 2011, 54:1570–9.
   PubMed Web of Science ®Google Scholar
• Matsumura T, Kato T, Sugiyama N, Tasaka-Fujita M, Murayama A, Masaki T, Wakita T, Imawari M. 25- Hydroxyvitamin D3 suppresses hepatitis C virus production. Hepatology 2012;56:1231–9.
   PubMed Web of Science ®Google Scholar
• Yano M, Ikeda M, Abe K, Dansako H, Ohkoshi S, Aoyagi Y, Kato N. Comprehensive analysis of the effects of ordinary nutrients on hepatitis C virus RNA replication in cell culture. Antimicrob Agents Chemother 2007;51: 2016–27.
   PubMed Web of Science ®Google Scholar
• Bitetto D, Fabris C, Fornasiere E, Pipan C, Fumolo E, Cussigh A, Bignulin S, Cmet S, Fontanini E, Falleti E, Martinella R, Pirisi M, Toniutto P. Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C. Transpl Int 2011;24:43–50.
   PubMed Web of Science ®Google Scholar
• Cholongitas E, Theocharidou E, Goulis J, Tsochatzis E, Akriviadis E, Burroughs K. Review article: the extra-skeletal effects of vitamin D in chronic hepatitis C infection. Aliment Pharmacol Ther 2012;35:634–46.
   PubMed Web of Science ®Google Scholar
• Arteh J, Narra S, Nair S. Prevalence of vitamin D deficiency in chronic liver disease. Dig Dis Sci 2010;55:2624–8.
   PubMed Web of Science ®Google Scholar
• George J, Ganesh HK, Acharya S, Bandgar TR, Shivane V, Karvat A, Bhatia SJ, Shah S, Menon PS, Shah N. Bone mineral density and disorders of mineral metabolism in chronic liver disease. World J Gastroenterol 2009;15:3516–22.
   PubMed Web of Science ®Google Scholar
• Miroliaee A, Nasiri-Toosi M, Khalilzadeh O, Esteghamati A, Abdollahi A, Mazloumi M. Disturbances of parathyroid hormone-vitamin D axis in non-cholestatic chronic liver disease: a cross-sectional study. Hepatol Int 2010;4:634–40.
   PubMed Web of Science ®Google Scholar
• Hollis BW, Johnson D, Hulsey TC, Ebeling M, Wagner CL. Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness. J Bone Miner Res 2011;26:2341–57.
   PubMed Web of Science ®Google Scholar
• Baur K, Mertens JC, Schmitt J, Iwata R, Stieger B, Eloranta JJ, Frei P, Stickel F, Dill MT, Seifert B, Ferrari HA, von Eckardstein A, Bochud PY, Müllhaupt B, Geier A; Swiss Hepatitis C Cohort Study Group. Combined effect of 25-OH vitamin D plasma levels and genetic vitamin D receptor (NR 1I1) variants on fibrosis progression rate in HCV patients. Liver Int 2012;32:635–43.
   PubMed Web of Science ®Google Scholar
• Kastens S, Grungreiff K, Tekamp C, Lunemann S, Jaroszewicz J, Cornberg M, Manns MP, Wedemeyer H. Serum zinc but not vitamin D levels are associated with disease severity and treatment response in chronic hepatitis C virus infection [Abstract]. J Hepatol 2011;54(Suppl.):S458.
   Google Scholar
• Stauber RE, Scherzer T, Putz-Bankuti C, Matejka J, Spindelboeck W, Zinober K, Beinhardt S, Wehr E, Stojakovic T, Kessler HH, Ferenci P, Obermayer-Pietsch B. Baseline vitamin D levels do not influence SVR in patients with chronic HCV genotype 1 or 4 infection undergoing peginterferon/ribavirin treatment. J Hepatol 2011; 54(Suppl.):S468.
   Google Scholar
• Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 2004;79:362–71.
   PubMed Web of Science ®Google Scholar
• Gutierrez JA, Jones KA, Fitzgerald RL, Allina J, Branch AD, Trump DL, Schooley RT, Wyles DL. Vitamin D metabolites inhibit replication of the hepatitis C virus [Abstract]. Hepatology 2010;52(Suppl.):704A.
   Web of Science ®Google Scholar
• van Etten E, Mathieu C. Immunoregulation by 1,25- dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol 2005;97:93–101.
   PubMed Web of Science ®Google Scholar
• Parravicini V, Caserta S. The immunomodulatory roles of vitamin D: new tricks for an old dog. Mol Interv 2010; 10:204–8.
   PubMedGoogle Scholar
• Bitetto D, Fattovich G, Fabris C, Ceriani E, Falleti E, Fornasiere E, Pasino M, Ieluzzi D, Cussigh A, Cmet S, Pirisi M, Toniutto P. Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C. Hepatology 2011;53:1118–26.
   PubMed Web of Science ®Google Scholar